Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

TPST Stock Forecast, Price Targets, Chart, Dividends & Analysis

Tempest Therapeutics Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

0.92
 
USD
  
-0.01
  
(-0.61%)
Previous close: 0.9301  Open: 0.93  Bid: 0.925  Ask: 0.9381
52 week range    
0.70   
   6.00
Mkt Cap: 39 M  Avg Vol (90 Days): 1,281,983
Last updated: Wednesday 19th February 2025
Search for a stock

Metrics

Growth

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

TPST Income Statement

Annual
Invalid dateDec-17Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-28.95-7.47-3.09-1.91
Basic EPS total-28.95-7.47-3.09-1.91
Basic weighted shares outstanding262823.01 M4 M12 M15 M
Cost of sales-790000.0
Depreciation-2 M339000.0374000.0638000.0381000.0
DepreciationAndAmortization-2 M339000.0374000.0638000.0381000.0
Diluted EPS total-321.81-28.95-7.47-3.09-1.91
Diluted normalized net income/share-7.47-3.09-1.91
Diluted weighted shares outstanding4 M12 M15 M
Earnings from equity interest-1 M
EarningsFromEquityInterestNetOfTax-1 M
GainOnSaleOfPPE100000.0
GeneralAndAdministrativeExpense6 M5 M10 M12 M12 M
Gross operating profit-495000.0
ImpairmentOfCapitalAssets-400000.0
Income before tax-85 M-19 M-28 M-36 M-29 M
Income restructuring and M&A4 M
Income taxes67000.0-2 M-4 M-3 M-2 M
Interest income155000.0
InterestExpenseNonOperating288000.01 M2 M1 M
MinorityInterests8000.0
MiscOtherSpecialCharges28000.090000.0-34000.0549000.01 M
Net income from total operations-85 M-19 M-28 M-36 M-29 M
NetIncomeCommonStockholders-85 M-19 M-28 M-36 M-29 M
NetIncomeContinuousOperations-85 M-19 M-28 M-36 M-29 M
NetNonOperatingInterestIncomeExpense-288000.0155000.0-1 M1 M349000.0
Normalized income-32 M
Operating income-84 M-19 M-27 M-35 M-29 M
Operating income before depreciation (EBITDA)-84 M-19 M-27 M-33 M-30 M
OperatingExpense84 M19 M27 M35 M29 M
Other income net-28000.0-90000.034000.0-51000.015000.0
OtherGandA6 M5 M10 M12 M12 M
OtherOperatingExpenses-200000.0-246000.0-357000.0-273000.0
OtherWriteDown-1 M
RentAndLandingFees6 M
Research & development expense78 M14 M17 M23 M17 M
ResearchExpense78 M14 M17 M23 M17 M
RestructringAndMnAIncome4 M
SalariesAndWages-762000.0
Selling Gen & administrative expense6 M5 M10 M12 M12 M
SellingAndMarketingExpense28 M
SellingExpense28 M
Special income/charges-4 M
Total Income available for interest expense (EBIT)-84 M-19 M-27 M-34 M-31 M
Total common shares outstanding1 M11 M22 M
Total net income-85 M-19 M-28 M-36 M-29 M
Total ordinary shares44 M44 M44 M44 M44 M
Total revenues295000.0
TotalExpenses84 M19 M27 M35 M29 M
TotalRevenue295000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader